Wollongong, Australia

Zinka Brkic

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: University of Wollongong. Active years: 2011-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zinka Brkic. Retrieved from https://idiyas.com/inventor/zinka-brkic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zinka Brkic: Innovator in Peptidic Compounds

Introduction

Zinka Brkic is a notable inventor based in Wollongong, Australia. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of peptidic compounds. With a total of two patents to her name, her work focuses on innovative solutions for treating bacterial infections and HIV.

Latest Patents

Zinka Brkic's latest patents include the development of peptidic compounds that provide a compound of formula I, II, III, and IV, along with their pharmaceutically acceptable derivatives. These compounds are designed for use in the treatment of bacterial infections and HIV infections. Additionally, her patents encompass pharmaceutical compositions that incorporate these innovative compounds.

Career Highlights

Zinka Brkic is affiliated with the University of Wollongong, where she conducts her research and development work. Her academic background and research endeavors have positioned her as a key figure in her field.

Collaborations

Zinka has collaborated with notable colleagues, including Timothy Patrick Boyle and Jonathan Alan Victor Coates, enhancing her research through teamwork and shared expertise.

Conclusion

Zinka Brkic's contributions to the field of pharmaceutical sciences through her innovative peptidic compounds highlight her role as a leading inventor. Her work continues to pave the way for advancements in the treatment of critical health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…